Your prediction
Pros and Cons of Nymox Pharmaceutical Corp. in the next few years
Pros
?
M***** P*******
?
G***** c******* t* c**********
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Nymox Pharmaceutical Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Nymox Pharmaceutical Corp. | - | - | - | - | - | - | - |
| Resverlogix Corp | 3.730% | -11.465% | 19.828% | 113.846% | 157.407% | -38.496% | -86.635% |
| Enwave Corporation | -2.680% | 2.941% | -6.250% | 75.000% | 52.174% | -29.883% | -75.439% |
| Aurinia Pharmaceuticals Inc. | 0.260% | -2.483% | 5.657% | 54.250% | 52.908% | 200.180% | 7.011% |
Comments
Nymox Pharmaceutical Co. (NASDAQ: NYMX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for NYMX provided by MarketBeat
Nymox Pharmaceutical Co. (NASDAQ: NYMX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for NYMX provided by MarketBeat
Nymox Pharmaceutical Co. (NASDAQ: NYMX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for NYMX provided by MarketBeat